Ken Cote, Rockland, ME—Ken Cote passed away on October 10, 2024, leaving behind a profound legacy of kindness, courage, and dedication. Ken had bravely battled multiple myeloma for 14 years, surpassing the initial prognosis of three to five years with unwavering faith and resilience. His passing has left an irreplaceable void in the lives of his loved ones and the broader community.
Ken was deeply loved by his family, particularly his wife, who cherishes the countless memories they shared. Known for his compassionate nature, Ken formed strong bonds with healthcare professionals at Maine Health and Dana Farber, who fondly referred to him as the "poster child of cancer." Beyond the medical community, his impact extended to business circles and the sober community, where he offered support, guidance, and hope to many.
A fundraiser organized by Miranda Kelly and Richard Whitman aims to honor Ken’s legacy and support his family during this challenging time. The funds will assist with end-of-life expenses, including a headstone and a commemorative service featuring a bike ride in the spring. So far, $50 has been raised from a generous donation by Richard Whitman.
Ken’s dedication to helping others continues to inspire. His family requests that those unable to contribute consider performing a selfless act in his honor, embodying the principles Ken lived by—morality, humility, and generosity.
We extend our deepest condolences to Ken’s family and friends during this time of loss. May his legacy of love and kindness continue to guide and comfort all who knew him.
Short Summary of Ken Cote
Aspect | Details |
---|---|
Name | Ken Cote |
Date of Passing | October 10, 2024 |
Fundraiser Created By | Miranda Kelly and Richard Whitman |
Goal Amount | Not specified |
Amount Raised | $50 |
Location | Rockland, ME |
Purpose | End-of-life expenses and commemorative service |
Our thoughts and prayers are with Ken’s family and community. May he rest in peace.
Note:This post was written and edited by Michael Miller, based on their expertise and research. It is intended for informational purposes only. It does not constitute legal advice. We welcome your feedback and questions on this content. Please feel free to contact us.